What is Substance Over Form?

How it works

The substance-over-form principle has deep roots in common-law tax (UK Ramsay doctrine, US Gregory v. Helvering 1935, US Frank Lyon Co. v. United States 1978) and civil-law equivalents (France abus de droit, Germany Außensteuergesetz, etc.). The core idea: a transaction's legal form can be ignored when it doesn't match its economic reality.

Modern manifestations:

• Statutory GAAR — UK GAAR (FA 2013), Canada s. 245 ITA, Australia Part IVA, India Chapter X-A, EU ATAD art. 6, France art. L64 LPF.
• Treaty PPT — denies treaty benefits where one of the principal purposes was to obtain them.
• US Economic Substance Doctrine — codified in §7701(o) (2010): transactions must have meaningful change in economic position other than tax effects.
• Beneficial owner challenges — looking through conduit structures to identify the actual beneficial recipient.
• Sham doctrine — common-law principle disregarding artificial arrangements with no commercial purpose.

What "substance" looks like

Genuine substance means real activity in the jurisdiction:

• People — qualified employees performing the relevant functions, paid arm's-length, working from local premises.
• Premises — physical office (or appropriate physical infrastructure) with operating expenses.
• Decision-making — board meetings held locally with directors physically present, properly minuted; key decisions documented as made in the jurisdiction.
• Operations — actual business activity (sales, R&D, manufacturing, service delivery) — not just paper transactions.
• Risk-bearing — the entity bears genuine commercial risk on the activities it conducts.

The bar varies with the entity's purpose. A pure equity-holding entity needs lighter substance than an operating subsidiary. An IP-licensing entity needs much more (R&D, technical staff, decision-making on commercial exploitation).

Where the principle bites

Common targets:

1. Conduit holding companies in treaty countries (Cyprus, Netherlands, Luxembourg, Mauritius) routing dividend / interest / royalty flows to ultimate offshore owners — denied treaty benefits via PPT or beneficial-owner challenges.
2. Letterbox subsidiaries in low-tax jurisdictions claiming profit attribution — recharacterised by the home jurisdiction's CFC, GAAR, or transfer-pricing rules.
3. Self-cancelling transactions structured purely for tax loss harvesting without economic effect — denied under sham/economic-substance doctrines.
4. Intermediate licensing IP holding without local R&D — fails BEPS modified nexus, denied patent box benefits.

Examples

• Cypriot SPV with no employees, no premises, no operating activity beyond holding shares in a UK Ltd. UK pays dividend to Cyprus → Cyprus pays dividend to BVI parent → BVI is the ultimate beneficial owner. UK denies the WHT reduction under PPT (and possibly beneficial-owner challenge): the Cypriot SPV is a conduit, the BVI is the actual beneficial owner. UK domestic 0% applies for portfolio investors but treaty access for genuine corporate routes is lost.
• French operating multinational with Luxembourg holding for European subsidiaries. Luxembourg holding has 8 staff, real Luxembourg office, board meetings in Luxembourg, M&A decisions made locally, treasury managed in Luxembourg. PPT challenge fails — Luxembourg holding has genuine substance and commercial purpose. Treaty benefits granted.

Common mistakes

• Confusing legal validity with substance. A properly-formed Luxembourg SPV is legally valid but may still fail substance scrutiny if it's a pure conduit.
• Relying on form-based structures from pre-BEPS era. Many holding structures designed before 2017 fail post-MLI substance / PPT analysis.
• Treating substance as a one-time setup. Substance must be maintained — staff continuing to work, board continuing to meet locally, decisions continuing to be made in the jurisdiction.
• Underestimating contemporaneous documentation requirements. Building substance evidence after a tax authority challenge is significantly harder than maintaining it as you go.